Vice President, Research
Thomas Wechsler has more than seven years of R&D experience in AAV-mediated gene therapy and ZFN-mediated genome editing.
Prior to joining Grace Science, LLC he held senior management roles at Sangamo Therapeutics, including Team Leader (Lysosomal Storage Disorders) and Senior Director of Research (Rare Diseases). Previously, Dr. Wechsler worked as a postdoctoral fellow in the Department of Chemical and Systems Biology at the Stanford University School of Medicine. Prior to that, from 2005 to 2010, he worked as a postdoctoral fellow in the Genetic Recombination Laboratory (Dr. Stephen C. West; Cancer Research UK) on homologous recombination and DNA repair. Dr. Wechsler received his Ph.D. in Biology from the Ludwig-Maximilians University in Munich, Germany after conducting his Ph.D. thesis work at the University of California, San Francisco.